A detailed history of Summit Wealth Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Summit Wealth Group, LLC holds 8,368 shares of PFE stock, worth $207,526. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,368
Previous 8,368 -0.0%
Holding current value
$207,526
Previous $234,000 3.42%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $211,375 - $247,692
8,368 New
8,368 $234,000
Q2 2023

Jul 26, 2023

SELL
$36.12 - $41.79 $16.8 Million - $19.4 Million
-464,267 Reduced 97.55%
11,665 $428,000
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $18.7 Million - $24.4 Million
475,932 New
475,932 $12,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $303,660 - $450,126
-7,349 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $288,448 - $370,536
7,349 New
7,349 $316,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Summit Wealth Group, LLC Portfolio

Follow Summit Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Wealth Group, LLC with notifications on news.